Bogdan Popescu

4PUBLICATIONS
25CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 01, 2026
Dynamic genetic and nongenetic RAS-pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy.

|Oct 27, 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML.

Bogdan Popescu, Matthew F Jones, Madison Piao

|Jul 15, 2025
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.

Bogdan Popescu, Matthew F Jones, Madison Piao

|Mar 07, 2023
Sidestepping SHP2 inhibition.

Bogdan Popescu, Kevin Shannon

Pageof 1

Frequent Collaborators

3 joint publications

Elliot Stieglitz

2 joint publications

Yana Pikman

2 joint publications

Aaron C Logan

2 joint publications

Elaine Tran